Clicky

BACTIGUARD HLDG B(5JE)

Description: Bactiguard Holding AB (publ), a medical device company, provides infection prevention solutions in orthopedics, urology, intravascular/critical care, dental, and wound care therapeutic areas in the United States, Sweden, Malaysia, India, Bangladesh, Indonesia, the Kingdom of Saudi Arabia, and internationally. The company's infection prevention solutions reduce the risk of infections and the use of antibiotics. Its product portfolio consists of Bactiguard infection protection (BIP) Foley Catheter, an indwelling urinary catheter that reduces microbial adhesion; BIP Central Venous Catheter, which reduces the risk of catheter related bloodstream infection and antibiotics; BIP Endotracheal Tube, that reduces the ventilator associated pneumonia, antibiotics, and healthcare costs; BIP Endotracheal Tube Evac, a tube that combines the subglottic secretion drainage with coating to reduce microbial adhesion; and BIP Foley TempSensor, an indwelling urinary catheter that offers surveillance and infection prevention. The company's products also include Hydrocyn aqua, an antimicrobial solution and gel for improved wound healing; and surgical sutures comprising non-absorbable, natural absorbable, synthetic absorable, and specialty sutures. In addition, it offers ZNN Bactiguard, an orthopedic trauma implants with infection prevention technology; and Aniocyn, a wound and skin care products for dogs, cats, horses, and other pets. Bactiguard Holding AB (publ) was founded in 2005 and is headquartered in Stockholm, Sweden.


Keywords: Antibiotics Infection Catheter Skin Care Products Drainage Pneumonia Urinary Tract Infection Healthcare Costs Central Venous Catheter Peripheral Venous Catheter Urinary Catheterization Ventilator Associated Pneumonia Infection Prevention Solutions Bactiguard Infection Protection Foley Catheter Infection Prevention Technology

Home Page: www.bactiguard.com

Vasagatan 11
Stockholm, 111 20
Sweden
Phone: 46 84 40 58 80


Officers

Name Title
Ms. Christine Lind Chief Executive Officer
Mr. Patrick Fruergaard Bach Chief Financial Officer
Mr. Mikael Sander Chief Operating Officer
Ms. Nina Nornholm Head of Corporate Communication & Investor Relations
Dr. Nathaniel Bachrach Ph.D. Interim Head of R&D

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 3.3973
Price-to-Sales TTM: 0.4331
IPO Date:
Fiscal Year End: December
Full Time Employees: 163
Back to stocks